Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / People / Peter DeYoung
Person

Peter DeYoung

Tracked across 3 events · 33 articles · First seen Apr 16, 2026 · Last active Aug 18, 2026

Sentiment
17
Attention
4
Events
3
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (3)
2 30
Business
Piramal Pharma Solutions unveils payload-linker suite
Impact: Peter DeYoung, CEO of Piramal Global Pharma, announced the launch of the new suite, highlighting its importance for U.S.-based innovation and manufacturing.
May 13, 2026 · 11 articles
2 20
Business
Piramal Pharma acquires Yapan Bio stake
On August 18, 2026, Piramal Group (PPL) completed the acquisition of an additional 40.67% stake in Yapan Bio, a Hyderabad-based CDMO specializing in vaccines and biologics, for a cash consideration of ₹76 crore (approximately $7.95…
Impact: CEO of Piramal Global Pharma; commented on the strategic value of the acquisition.
Jul 20, 2026 · 11 articles
4 0
Business
Piramal, Ajinomoto Collaborate on ADC Manufacturing
Impact: Peter DeYoung, CEO of Piramal Global Pharma, expressed excitement about the collaboration, highlighting its potential to accelerate innovation and expand access to technology.
Apr 16, 2026 · 11 articles
ERGEN INTELLIGENCE
Track Peter DeYoung live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.